SCHEMBL7130746

SCHEMBL7130746

CC(=O)Nc1nc(-c2ccc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)cc2)cs1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.69
ABL1 P00519 5/20 0.58
KMT2A Q03164 6/20 0.57
PPARG P37231 5/20 0.57
MAPT P10636 4/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
CYP3A4 P08684 2/20 0.57
MAPK1 P28482 2/20 0.57
ALOX15 P16050 1/20 0.57
PPARA Q07869 1/20 0.57
MEN1 O00255 5/20 0.56
RORC P51449 2/20 0.56
LMNA P02545 2/20 0.56
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
PKM P14618 1/20 0.56
TSHR P16473 1/20 0.56
NFKB1 P19838 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7120002 0.96 RAB9A (0.66) RAB9AABL1KMT2APPARGMAPT
SCHEMBL7128929 0.90 RAB9A (0.67) RAB9AKMT2APPARGMAPTSMN1; SMN2
SCHEMBL7123649 0.90 MEN1 (0.62) RAB9AABL1KMT2APPARGMAPT
SCHEMBL7127823 0.87 PPARG (0.60) KMT2APPARGMAPTSMN1; SMN2CYP3A4
SCHEMBL7129934 0.87 RAB9A (0.56) RAB9AABL1KMT2APPARGMAPT
SCHEMBL7119667 0.86 RAB9A (0.53) RAB9AKMT2APPARGMAPTSMN1; SMN2
SCHEMBL7125386 0.86 RAB9A (0.59) RAB9AABL1KMT2APPARGMAPT
SCHEMBL7127621 0.86 ABL1 (0.63) RAB9AABL1KMT2AMAPTSMN1; SMN2
SCHEMBL7128794 0.86 MEN1 (0.69) RAB9AKMT2APPARGMAPTSMN1; SMN2
SCHEMBL7128853 0.86 MAPT (0.62) RAB9AABL1KMT2APPARGMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US claimed
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD RAB9A 1179/4885ABL1 2719/4885KMT2A 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.